Rincell-3

N/A

Report date: 2025/07/23 16:30:16

Base Information

Drug NameRincell-3
Drug Alias NameRincell-3
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsHearing Loss, Sensorineural
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRinri Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRinri Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsHearing Loss, Sensorineural
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A